Trial Information

Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing

All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center
and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer
will be asked to participate in this study by completing a questionnaire.

This study will end when 400 completed questionnaires have been collected. We estimate that
40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer
Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of
Houston each week. The completion of 400 questionnaires will provide adequate data to
address our question in an expeditious time frame. The initial phase of this study is
exploratory and does not involve a comparison group.